BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Seattle Genetics, Inc., Takeda Pharmaceutical Co. Ltd.'s Cancer Drug Meets Main Goal In Phase 3 Trial     9/29/2014
Baxter International, Inc. Inks A $970 Million Pact For Merrimack Pharmaceuticals Inc.'s Lead Cancer Drug MM-398     9/25/2014
Amgen Asks FDA For Biologics License For Breakthrough Cancer Drug Blinatumomab     9/24/2014
Soligenix Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million     9/19/2014
Merck KGaA Wants Bids For Cancer Therapy Partners     9/18/2014
Roche Battles Counterfeit Rituxin Vials In Germany     9/15/2014
FDA Approves Merck & Co.'s New-Kind Of Cancer Drug Keytruda     9/8/2014
AbbVie Hands Over $275 Million Upfront For Infinity Pharmaceuticals Inc.’s Blood Cancer Drug; Deal Could Be Worth $805 Million     9/5/2014
Tiny Redx Pharma Signs "Transformational" Cancer Deal With AstraZeneca PLC; Financial Terms Have Not Been Disclosed     9/4/2014
XBiotech USA, Inc. Halts Cancer Study On Positive Phase 3 Results     9/2/2014
OncoMed Pharmaceuticals, Inc. Says FDA Lifts Partial Hold On Cancer Drug Trials For Vantictumab     8/29/2014
Boston Startup OncoPep Secures $6.9 Million Series B Financing     8/28/2014
Illumina, Inc. Partners With AstraZeneca PLC, Johnson & Johnson To Create New Genetic Tests For Cancer     8/21/2014
Confirmed: Novartis AG To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal     8/19/2014
San Diego's Telik, Inc. Appoints New Board Members To Oversee Reinvigorated Cancer Pipeline     8/12/2014
 Featured Stories
Tattoo Ink Linked To Skin Cancer Risk, PRS Global Open Reveals     9/23/2014
Wild Berry Extract May Boost Effect Of Pancreatic Cancer Drug, University of Southampton Study     9/23/2014
Exercise Boosts Tumor-Fighting Ability Of Chemotherapy, University of Pennsylvania Team Finds     9/22/2014
Angelina Jolie Surgery Sparks Surge In Female Cancer Tests     9/19/2014
Certain Form Of Baldness Linked To Prostate Cancer, National Cancer Institute Study     9/17/2014
UV Light Can Turn Gene Into Source Of Skin Cancers, Stanford University School of Medicine Study     9/10/2014
Prediabetes Increases The Risk Of Cancer By 15 Percent, The First People's Hospital Of Shunde Reveals     9/10/2014
Bras Cause Breast Cancer? Apparently Not, Fred Hutchinson Cancer Research Center Study     9/5/2014
Severing Nerves May Shrink Stomach Cancers, Columbia University Medical Center Study     8/21/2014
Children Face Higher Health Risk From Cell Phones, Environmental Health Trust Reveals     8/21/2014
Injected Bacteria Shrink Tumors In Rats, Dogs And Humans, Johns Hopkins University Study     8/20/2014
What Are The Health Benefits Of Bok Choy?     8/15/2014
Excess Body Weight Boosts Risk Of 10 Common Cancers, Lancet Study Reports     8/15/2014
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals     8/7/2014
Daily Dose Of Aspirin Can Cut Deaths From Three Kinds Of Cancer, Queen Mary University Of London Reveals     8/7/2014
 More News
Janssen Research & Development Release: ZYTIGA® Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis In Chemotherapy-Naive Men With Metastatic Castration-Resistant Prostate Cancer     9/29/2014
Cancer Treatment Institute Of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination Of 3-Bromopyruvate And Salinomycin For Treatment Of Multiple Types Of Cancer     9/29/2014
Arisaph Pharmaceuticals, Inc. Awarded Supplemental Phase I And Phase 2 STTR Grants To Develop Oncology Drug Candidates     9/29/2014
AbbVie (ABBV) Presents Results From Multiple Studies Of Investigational Compound Veliparib In Patients With Non-Small Cell Lung Cancer At The European Society For Medical Oncology Annual Congress     9/29/2014
Immunomedics, Inc. (IMMU) Publishes Results On Immunotherapy Of Solid Cancers Mediated By A Novel Bispecific Antibody     9/26/2014
Agios Pharmaceuticals (AGIO) To Present Clinical Data From AG-120 Ongoing Phase 1 Study In Hematologic Malignancies At EORTC-NCI-American Association for Cancer Research 2014     9/26/2014
MabVax Therapeutics, Inc. Receives Orphan Drug Designation For Therapeutic Vaccine To Treat Childhood Cancer Neuroblastoma     9/25/2014
Thermo Fisher Scientific (TMO) Announces Agreement With GlaxoSmithKline (GSK) And Pfizer (PFE) To Develop Oncology Companion Diagnostics Using Next-Generation Sequencing (NGS)     9/25/2014
NCKU Research Team Reveals Key Mechanism In Lung Cancer     9/25/2014
Karmanos Cancer Institute's 21st Annual Partners Events Raise More Than $916,000 For Cancer Survivorship Research     9/25/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Expands Cancer Immunotherapy Platform With Antigen-Specific T-Cell Technology Licensed From California Institute of Technology     9/24/2014
Inovio Pharmaceuticals (INO) Expands HPV Immunotherapy Development To Aerodigestive Cancers     9/22/2014
AbbVie (ABBV) To Present Clinical Study Data On Potential New Oncology Medicines At The 2014 European Society Of Medical Oncology Annual Meeting     9/22/2014
Haukeland University Hospital Release: Pilot Study Shows Promise for Treatment of Pancreatic Cancer     9/19/2014
OXiGENE (OXGN) Initiates Phase 2 Study Of Fosbretabulin In Gastrointestinal Neuroendocrine Tumors     9/18/2014